The combination of CD16A/EGFR bispecific innate cell engager AFM24 with SNK01 NK cells promotes efficacious targeting and killing of EGFR+ tumor cells
Pahl et al.
AACR-NCI-EORTC 2021 - AFM24
Pahl et al.
AACR-NCI-EORTC 2021 - AFM24
Wingert et al.
mAbs 2021; 13(1): 1950264
Kerbauy et al.
Clinical Cancer Research; 27: 3744-3756.
Pahl et al.
AACR 2021 - AFM24
Sawas et al.
ASH 2020 - AFM13
Bartlett et al.
Blood 2020; 136: 2401–2409.
Reusch et al.
AACR 2020 - AFM24
Harstrick et al.
ASCO 2020 - AFM13
Ellwanger et al.
NK2019 - ROCK®
Marin et al.
NK2019 - AFM13